We are live on ! Find out more
ANGO icon

AngioDynamics

132 hedge funds and large institutions have $477M invested in AngioDynamics in 2014 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

566% more call options, than puts

Call options by funds: $2.77M | Put options by funds: $416K

193% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 15

44% more capital invested

Capital invested by funds: $331M → $477M (+$145M)

26% more funds holding

Funds holding: 105132 (+27)

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
132
Holders Change
+27
Holders Change %
+25.71%
% of All Funds
3.51%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
44
Increased
40
Reduced
34
Closed
15
Calls
$2.77M
Puts
$416K
Net Calls
+$2.35M
Net Calls Change
+$1.97M

ANGO Hedge Fund Activity: Q4 2014 in Review

132 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2014, worth a combined $477M — up 44% from $331M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new ANGO positions and 15 closed out — a net gain of 29 holders — while 40 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $14.9M. The largest seller was RGM Capital, cutting an estimated $12.6M.

  • 132 institutional investors held AngioDynamics (ANGO) as of Q4 2014, up from 105 in Q3 2014.
  • Funds reported $477M of AngioDynamics stock for Q4 2014, up 44% quarter-over-quarter.
  • 44 funds opened new AngioDynamics positions in Q4 2014 and 15 closed out, a net change of +29 holders.
  • The largest AngioDynamics buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $14.9M added.
  • The largest AngioDynamics seller in Q4 2014 was RGM Capital, an estimated $12.6M sold.

Based on aggregated 13F filings for Q4 2014.